Cargando…
Direct access valve-in-valve implantation for management of complex valvulopathy
The management of bioprosthetic structural valve degeneration requires complex surgical or transcatheter re-intervention for which many high-risk patients are not considered candidates. Here, we describe a technique for a direct surgical access valve-in-valve implantation in patients with complex bi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557424/ https://www.ncbi.nlm.nih.gov/pubmed/30963696 http://dx.doi.org/10.1002/ccd.28179 |
_version_ | 1783425450543939584 |
---|---|
author | Kossar, Alexander P. Borger, Michael George, Isaac |
author_facet | Kossar, Alexander P. Borger, Michael George, Isaac |
author_sort | Kossar, Alexander P. |
collection | PubMed |
description | The management of bioprosthetic structural valve degeneration requires complex surgical or transcatheter re-intervention for which many high-risk patients are not considered candidates. Here, we describe a technique for a direct surgical access valve-in-valve implantation in patients with complex bioprosthetic valvulopathy for whom standard surgical valve replacement and percutaneous interventions were high-risk and contraindicated, respectively. |
format | Online Article Text |
id | pubmed-6557424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
record_format | MEDLINE/PubMed |
spelling | pubmed-65574242020-06-01 Direct access valve-in-valve implantation for management of complex valvulopathy Kossar, Alexander P. Borger, Michael George, Isaac Catheter Cardiovasc Interv Article The management of bioprosthetic structural valve degeneration requires complex surgical or transcatheter re-intervention for which many high-risk patients are not considered candidates. Here, we describe a technique for a direct surgical access valve-in-valve implantation in patients with complex bioprosthetic valvulopathy for whom standard surgical valve replacement and percutaneous interventions were high-risk and contraindicated, respectively. 2019-04-08 2019-06-01 /pmc/articles/PMC6557424/ /pubmed/30963696 http://dx.doi.org/10.1002/ccd.28179 Text en http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Kossar, Alexander P. Borger, Michael George, Isaac Direct access valve-in-valve implantation for management of complex valvulopathy |
title | Direct access valve-in-valve implantation for management of complex
valvulopathy |
title_full | Direct access valve-in-valve implantation for management of complex
valvulopathy |
title_fullStr | Direct access valve-in-valve implantation for management of complex
valvulopathy |
title_full_unstemmed | Direct access valve-in-valve implantation for management of complex
valvulopathy |
title_short | Direct access valve-in-valve implantation for management of complex
valvulopathy |
title_sort | direct access valve-in-valve implantation for management of complex
valvulopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557424/ https://www.ncbi.nlm.nih.gov/pubmed/30963696 http://dx.doi.org/10.1002/ccd.28179 |
work_keys_str_mv | AT kossaralexanderp directaccessvalveinvalveimplantationformanagementofcomplexvalvulopathy AT borgermichael directaccessvalveinvalveimplantationformanagementofcomplexvalvulopathy AT georgeisaac directaccessvalveinvalveimplantationformanagementofcomplexvalvulopathy |